🔎 Trials Near Me

Home › Atrial Fibrillation › NCT05510167

Post-ablation Alcohol Impacts Arrhythmia Recurrence, Quality of Life and Cognition in AF

Recruiting

Impact of Post-ablation Alcohol Intake on Arrhythmia Recurrence, Quality of Life and Cognition in Patients With Atrial Fibrillation

Who can join

Ages 18 to 85 · All sexes

Full eligibility criteria
Inclusion Criteria:

* AF patients that regularly consume \>5 alcoholic drink (\*12 g of pure alcohol/drink)/week
* Paroxysmal or persistent AF
* First catheter ablation History of alcohol-induced arrhythmia
* Willing to sign the written informed consent

Exclusion Criteria:

* Binge drinkers (alcohol dependence)
* Non-drinkers
* LVEF \<35%
* Psychiatric conditions
* MoCA score ≤ 17 on Montreal Cognitive Assessment (MoCA)
* Patients with established dementia
* Medically unstable patients (acute/unstable or poorly controlled problems that would demand focused, relatively urgent or emergent medical attention)
* Unwilling for alcohol-abstinence
* Long-standing persistence AF
* Patient under legal protection
* Pregnancy

About the study

Earlier studies have shown a dose-dependent relationship between alcohol intake and incident atrial fibrillation (AF) as well as a causal link with several risk factors for AF such as hypertension, obesity and sleep apnea. However, the effect of drinking (alcohol) on post-ablation outcome such as arrhythmia recurrence, quality of life (QoL) and cognitive function in AF patients is unclear. Therefore, we aim to find the answer for a very frequently asked question, "is it safe to continue drinking alcohol (at the pre-ablation level) following catheter ablation OR should the intake be reduced for better outcome?", in this randomized trial.

What is being tested

Sponsor: Texas Cardiac Arrhythmia Research Foundation · Participants: 184 · Started: Aug 22, 2022

Contact the study team

Official record on ClinicalTrials.gov — NCT05510167

Locations in the U.S.

TexasTexas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.